Darifenacin

In the US, Darifenacin (darifenacin systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:

• Darifenacin Extended-Release Tablets


• Darifenacin


• Darifenacin Hydrobromide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04BD10

CAS registry number (Chemical Abstracts Service)

0133099-04-4

Chemical Formula

C28-H30-N2-O2

Molecular Weight

426

Therapeutic Category

Antispasmodic agent

Chemical Names

(S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide (WHO)

(S)-1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-Õ,α-diphenylpyrrolidin-3-acetamid (IUPAC)

(S)-2-{1-[2-(2,3-Dihydrobenzo[b]furan-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide (BAN)

Foreign Names

• Darifenacinum (Latin)
• Darifenacin (German)
• Darifénacine (French)
• Darifenacina (Spanish)

Generic Names

• Darifenacin (OS: BAN, USAN)
• Dasifenacin (IS)
• UK 88525 (IS: Pfizer)
• Darifenacin Hydrobromide (OS: BANM, USAN)
• UK 88525-04 (IS: Pfizer)

Brand Names

• Enablex
  Bayer Schering, South Africa



• Emselex
  Bayer, Germany; Novartis, Belgium; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, United Kingdom; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Iceland; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis Pharmaceuticals, Peru



• Enablex
  Novartis, Australia; Novartis, Canada; Novartis, United States

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.